Skip to main content

Table 1 Clinical Characteristics of Patient Population (n = 10)

From: Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy

Case No. Age CV risk Radiotherapy Baseline LVEF (%) Post Chemothx LVEF (%) Trastuzumab Duration
1 33 None Yes 55 52 4 months
2 41 HTN Yes 60 58 5 months
3 27 None Yes 54 56 4 months
4 39 None Yes 65 62 3 months
5 44 Lipids Yes 58 55 4 months
6 38 None Yes 56 52 5 months
7 56 HTN Yes 60 62 3 months
8 45 HTN Yes 54 55 4 months
9 32 None Yes 55 52 5 months
10 40 HTN Yes 60 58 4 months
  1. CV, cardiovascular; LVEF, left ventricular ejection fraction; chemothx, chemotherapy; HTN, hypertension.